These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 12163125)

  • 21. Exploiting genomics, genetics and chemistry to combat antibiotic resistance.
    Hughes D
    Nat Rev Genet; 2003 Jun; 4(6):432-41. PubMed ID: 12776213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of genomics on novel antibacterial targets.
    Payne DJ; Wallis NG; Gentry DR; Rosenberg M
    Curr Opin Drug Discov Devel; 2000 Mar; 3(2):177-90. PubMed ID: 19649849
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive essential gene identification as a platform for novel anti-infective drug discovery.
    Haselbeck R; Wall D; Jiang B; Ketela T; Zyskind J; Bussey H; Foulkes JG; Roemer T
    Curr Pharm Des; 2002; 8(13):1155-72. PubMed ID: 12052225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-genome sequencing to control antimicrobial resistance.
    Köser CU; Ellington MJ; Peacock SJ
    Trends Genet; 2014 Sep; 30(9):401-7. PubMed ID: 25096945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel approaches to the discovery of antimicrobial agents.
    Schmid MB
    Curr Opin Chem Biol; 1998 Aug; 2(4):529-34. PubMed ID: 9736927
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exploiting genomics to discover new antibiotics.
    McDevitt D; Rosenberg M
    Trends Microbiol; 2001 Dec; 9(12):611-7. PubMed ID: 11728875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. When will the genomics investment pay off for antibacterial discovery?
    Mills SD
    Biochem Pharmacol; 2006 Mar; 71(7):1096-102. PubMed ID: 16387281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic approaches to antibacterial discovery.
    Payne DJ; Gwynn MN; Holmes DJ; Rosenberg M
    Methods Mol Biol; 2004; 266():231-59. PubMed ID: 15148422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developing antibacterial vaccines in genomics and proteomics era.
    Kaushik DK; Sehgal D
    Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cloning and targeted disruption of two lipopolysaccharide biosynthesis genes, kdsA and waaG, of Pseudomonas aeruginosa PAO1 by site-directed mutagenesis.
    Perumal D; Sakharkar KR; Tang TH; Chow VT; Lim CS; Samal A; Sugiura N; Sakharkar MK
    J Mol Microbiol Biotechnol; 2010; 19(4):169-79. PubMed ID: 21042030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The decline of antibiotic era--new approaches for antibacterial drug discovery.
    Jagusztyn-Krynicka EK; Wyszyńska A
    Pol J Microbiol; 2008; 57(2):91-8. PubMed ID: 18646395
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biocomputational strategies for microbial drug target identification.
    Sakharkar KR; Sakharkar MK; Chow VT
    Methods Mol Med; 2008; 142():1-9. PubMed ID: 18437301
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genomics strategies for antifungal drug discovery--from gene discovery to compound screening.
    Willins DA; Kessler M; Walker SS; Reyes GR; Cottarel G
    Curr Pharm Des; 2002; 8(13):1137-54. PubMed ID: 12052224
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of the Subtractive Genomics and Molecular Docking Analysis for the Identification of Novel Putative Drug Targets against
    Hossain T; Kamruzzaman M; Choudhury TZ; Mahmood HN; Nabi AHMN; Hosen MI
    Biomed Res Int; 2017; 2017():3783714. PubMed ID: 28904956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Harnessing the power of the genome in the search for new antibiotics.
    Rosamond J; Allsop A
    Science; 2000 Mar; 287(5460):1973-6. PubMed ID: 10720317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel targets for the future development of antibacterial agents.
    McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
    Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From microbial gene essentiality to novel antimicrobial drug targets.
    Mobegi FM; van Hijum SA; Burghout P; Bootsma HJ; de Vries SP; van der Gaast-de Jongh CE; Simonetti E; Langereis JD; Hermans PW; de Jonge MI; Zomer A
    BMC Genomics; 2014 Nov; 15(1):958. PubMed ID: 25373505
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small and lethal: searching for new antibacterial compounds with novel modes of action.
    Pathania R; Brown ED
    Biochem Cell Biol; 2008 Apr; 86(2):111-5. PubMed ID: 18443624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivering novel targets and antibiotics from genomics.
    Payne DJ; Holmes DJ; Rosenberg M
    Curr Opin Investig Drugs; 2001 Aug; 2(8):1028-34. PubMed ID: 11892909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.